Sandra A. G. Visser

A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group

NC Barnes, Gianni Marone, GU Di Maria et al. · European Respiratory Journal · 1993 · 159 citations · Full text

Asthma, Allergy, Allergy Medicine +14

Model‐Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives

Scott Marshall, Rajanikanth Madabushi, Efthymios Manolis et al. · CPT Pharmacometrics & Systems Pharmacology · 2018 · 119 citations · Full text

Preclinical Therapeutics, Future Perspectives, Us Food +18

Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Electroencephalogram Effects of GABAA Receptor Modulators: In Vitro-in Vivo Correlations

Sandra A. G. Visser, Francisca L.C. Wolters, J. M. Gubbens‐Stibbe et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 84 citations

Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: prediction of tissue-dependent efficacy in vivo.

Piet H. van der Graaf, E.A. van Schaick, Sandra A. G. Visser et al. · PubMed · 1999 · 70 citations

Pharmacotherapy, Experimental Pharmacology, Physiologically-based Pharmacokinetic Modeling +17

Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler

Jean Bousquet, Anthony D’Urzo, Jean‐Louis Hébert et al. · European Respiratory Journal · 2000 · 58 citations · Full text